I mentioned a number of issues in my opening statement, but I think the current priorities for.... First of all, everything is a priority for women's health. All of the issues we're looking at, we're also looking at with a lens in terms of impacts on women. Speaking for the health portfolio and not just for the department, sexual reproductive health is a key priority as are cancer research and breast cancer screening.
We have a scientific advisory committee, as my colleague mentioned, that's looking at medical devices and their impact on women, and we have the drug regulatory. There's not a health issue that doesn't have an impact on women and doesn't require that attention.